Women’s Health & OB/GYN News

Screening pregnancies without traditional risk factors for spontaneous preterm birth risk with a biomarker blood test and targeting preventive treatments for high-risk women reduced neonatal hospitalization, morbidity and mortality.

Women with early pregnancy loss who received misoprostol alone without pretreatment with mifepristone were more likely to receive subsequent procedural management and have visits to the ED, researchers reported.

Prior testosterone exposure did not impact oocyte cryopreservation outcomes among transgender and gender-diverse adolescents and young adults, according to a research letter published in Obstetrics & Gynecology.

Healio has announced the 2024 honorees of its peer-to-peer recognition program, Healio Honors.

According to published results, postoperative sexual education counseling may improve patient satisfaction, sexual function and quality of life for sexually active women who undergo total hip arthroplasty.

Many postmenopausal women self-reported moderate or higher vasomotor symptoms in the primary care setting but remained untreated due to lack of electronic health record documentation, researchers reported.

This is the second respiratory disease season with two new powerful tools to protect infants from severe respiratory syncytial virus disease, and experts are optimistic that uptake will improve from last season.

Breast Cancer Awareness Month is observed every October.

Overall provision of medication abortion via a single online pharmacy was higher after the Dobbs v. Jackson decision, with much of the increase being driven by prescriptions from virtual-only providers, researchers reported.

When counseling women with kidney disease about pregnancy, nephrologists and women’s health providers must emphasize intentionality.